Form D · Manufacturing
SiGNa Chemistry, Inc.
New York, NY · CIK 0001632876
Offering snapshot reported Feb 11, 2015 · SEC filing
- Reported sold
- $24.5M Offering amount: $24.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 27, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2015 | Initial | $24,513,269 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-233936
Amount sold includes $4,513,269 which was converted from debt to equity. As part of offering, one Investor also acquired a Warrant to purchase Series D-1 Preferred Stock.
Source: Form D, filed Feb 11, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Katherine Carney | Executive |
| Peter Cash | Executive |
| Nael Kassar | Director |
| Mack Knobbe | Executive |
| Paul Krumrine | Executive |
| Michael Lefenfeld | Director, Executive, Promoter |
| Mark A. Lester | Director |
| Jeffrey Seidel | Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
445 Park Avenue Suite 937
New York, NY, 10022
New York, NY, 10022